Amneal Pharmaceuticals (AMRX) Gross Margin Growth (3y) (2020 - 2026)
Analysis
Amneal Pharmaceuticals (AMRX) Gross Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 567.00 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -228.00 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -1,218.00 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 528.00 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 313.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 32,526.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -137.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 91.00 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 42.00 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 528.00 |
| Mar 31, 2026 | 1,235.00 |
| Dec 31, 2025 | 117.00 |
| Sep 30, 2025 | -68.00 |
| Jun 30, 2025 | 366.00 |
| Mar 31, 2025 | 172.00 |
| Dec 31, 2024 | 499.00 |
| Sep 30, 2024 | 82.00 |
| Jun 30, 2024 | -410.00 |
| Mar 31, 2024 | -273.00 |
| Dec 31, 2023 | -199.00 |
| Sep 30, 2023 | 1,178.00 |
| Jun 30, 2023 | 569.00 |
| Mar 31, 2023 | -485.00 |
| Dec 31, 2022 | 758.00 |
| Sep 30, 2022 | 2,121.00 |
| Jun 30, 2022 | 984.00 |
| Mar 31, 2022 | 1,646.00 |
| Dec 31, 2021 | -788.00 |
| Sep 30, 2021 | -444.00 |